is a topic covered in the Johns Hopkins ABX Guide
To view the entire topic, please sign in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).
- Treatment of serious RSV pneumonia in immunocompromised adult patients (limited data).
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: November 2, 2015
Pham, Paul A. "Palivizumab." Johns Hopkins ABX Guide, The Johns Hopkins University, 2015. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab.
Pham PA. Palivizumab. Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab. Accessed October 16, 2019.
Pham, P. A. (2015). Palivizumab. In Johns Hopkins ABX Guide. Available from https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab
Pham PA. Palivizumab [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. [cited 2019 October 16]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab.
TY - ELEC
T1 - Palivizumab
ID - 540413
A1 - Pham,Paul,Pharm.D. BCPS
Y1 - 2015/11/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine